Topcon Medical Laser Systems has received 510(k) clearance from the U.S. Food and Drug Administration for its portable, dual-port, pattern-scanning laser, the Pascal Synthesis, according to a news release.
The device, which is available in 532nm and 577nm wavelengths, can be integrated with both Topcon D7 and Haag-Streit-style slit lamps.
The combination will allow physicians the opportunity to use pattern-scanning laser technology to treat retinal disorders such as diabetic retinopathy, age-related macular degeneration, and retinal vascular occlusive disease using a slit lamp set up.
Topcon also offers Endpoint Management as an upgrade on the Synthesis lasers, which is intended to provide increased precision, efficiency, and control, according to the release.
Latest from Today's Medical Developments
- GrindingHub Americas launches in 2027 in Cincinnati, Ohio
- Methods Machine Tools now offers the Nakamura-Tome NT-Flex
- Battelle awards $900,000 in STEM education grants to Ohio schools
- #55 Lunch + Learn Podcast with KINEXON
- Starrett and Gerstner offer limited edition, American made 1950s replica wooden machinist tool chests
- EMCO’s UNIVERSALTURN 50: The new benchmark in universal turning
- Archetype's Expertise for Equity accelerates early-stage innovation
- Stratasys expands its AM solutions with Tritone's cutting-edge technology
